Remala Abadi Tbk PT
IDX:DATA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Remala Abadi Tbk PT
IDX:DATA
|
ID |
|
Japan Foods Holding Ltd
SGX:5OI
|
SG |
|
Omega Therapeutics Inc
NASDAQ:OMGA
|
US |
|
Rhoen Klinikum AG
XETRA:RHK
|
DE |
Income Statement
Earnings Waterfall
Remala Abadi Tbk PT
Income Statement
Remala Abadi Tbk PT
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
2 555
|
2 566
|
0
|
0
|
|
| Revenue |
348 192
N/A
|
375 834
+8%
|
424 618
+13%
|
413 613
-3%
|
|
| Gross Profit | |||||
| Cost of Revenue |
(84 612)
|
(91 327)
|
(100 431)
|
(85 924)
|
|
| Gross Profit |
263 580
N/A
|
284 507
+8%
|
324 188
+14%
|
327 688
+1%
|
|
| Operating Income | |||||
| Operating Expenses |
(116 169)
|
(133 925)
|
(153 250)
|
(158 092)
|
|
| Selling, General & Administrative |
(107 051)
|
(123 794)
|
(143 992)
|
(147 081)
|
|
| Depreciation & Amortization |
(10 509)
|
(11 663)
|
(10 649)
|
(10 603)
|
|
| Other Operating Expenses |
1 391
|
1 532
|
1 390
|
(408)
|
|
| Operating Income |
147 411
N/A
|
150 582
+2%
|
170 937
+14%
|
169 597
-1%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
(1 875)
|
(1 669)
|
(2 475)
|
(7 249)
|
|
| Non-Reccuring Items |
142
|
0
|
(5 717)
|
(5 717)
|
|
| Total Other Income |
(455)
|
(36)
|
(11 058)
|
(10 656)
|
|
| Pre-Tax Income |
145 223
N/A
|
148 878
+3%
|
151 687
+2%
|
145 976
-4%
|
|
| Net Income | |||||
| Tax Provision |
(33 377)
|
(34 682)
|
(35 249)
|
(33 455)
|
|
| Income from Continuing Operations |
111 847
|
114 195
|
116 438
|
112 521
|
|
| Income to Minority Interest |
(2 853)
|
(3 200)
|
(2 311)
|
(3 463)
|
|
| Net Income (Common) |
96 590
N/A
|
98 591
+2%
|
101 724
+3%
|
109 058
+7%
|
|
| EPS (Diluted) |
75.52
N/A
|
71.7
-5%
|
73.98
+3%
|
79.3
+7%
|
|